Page URL:

Illumina claims the $1,000 genome crown

20 January 2014
Appeared in BioNews 738

The $1,000 genome may have arrived, an achievement which would mark a significant milestone in the application of genetic science. The US $1,000 price tag for sequencing a human genome has long been seen as the threshold at which large-scale human genomics research and personalised medicine would become affordable, but has proved hard to attain.

The biotechnology company Illumina announced that its new high-speed sequencing supercomputer – named HiSeq X – will be able to sequence 20,000 human genomes per year, at a cost of $1,000 each. The new sequencer will launch 'the supersonic age of genomics', according to Jay Flatley, the company's chief executive officer, speaking at the JP Morgan Healthcare Conference in San Francisco.

Several commentators anticipate considerable impact in cancer research. 'Over the next few years, we have an opportunity to learn as much about the genetics of human disease as we have learned in the history of medicine', said Professor Eric Lander, founding director of the Broad Institute of Massachusetts Institute of Technology and Harvard University, and one of the first customers for the HiSeq X.

Faster and cheaper technology would allow researchers to sequence the genomes of hundreds of thousands of people, gaining a better understanding of the complex genetic variation that can lead to cancer and many other diseases. Population-level genomics research – such as the UK's 100K Genomes project that aims to sequence 100,000 NHS patient genomes over the next five years – should become more cost effective.

Personalised medicine may also benefit as patients can have their genomes sequenced or tumour genetics analysed more affordably, with the information used to guide treatment. However, even if Illumina has produced the first $1,000-a-genome sequencer, it will still be a while before personal genome sequencing will be available to the public at that price.

It took 13 years and $3 billion to sequence the first human genome more than a decade ago. According to Bloomberg, the current cost runs at around $10,000. Illumina attributes the further drop in cost mainly to improvements in the chemical reagents involved in sequencing - more efficient enzymes and brighter fluorescent dyes needed to identify the units of DNA.

Talking to Nature, Dr Michael Schatz from Cold Spring Harbor Laboratory in the USA said Illumina had made 'a major human accomplishment on par with the development of the telescope or the microprocessor'.

'If there was any doubt to if genomics would ever be able to reach the everyday man, at this price point and efficiencies it is absolute certainty', he said.

The $1,000 price tag includes the cost of reagents ($797 per genome), the cost of purchasing the machine ($137 per genome) and the labour costs involved in preparing samples and running the machine ($55 to 65 per genome). It does not, however, include the costs of analysing the data, or overhead costs such as electricity.

The HiSeq X sequencer is the size of a large photocopier, costs $1 million and is only sold in units of ten or more. There are already a number of high-profile customers, including the Broad Institute, the Garvan Institute of Medical Research in Sydney, Australia, and the biotechnology company Macrogen in Seoul, South Korea.

Other companies - Ion Torrent, owned by Life Technologies (see BioNews 640), and the UK-based Oxford Nanopore - have previously promised products capable of sequencing a human genome for $1,000, but these have yet to materialise. The HiSeq X is expected to be delivered to its first clients by March 2014.

Cheap DNA: What the $1000-genome means for you
New Scientist |  17 January 2014
Illumina hits the $1,000 genome mark with a big-data 'cannonball'  Read more: Illumina hits the $1,000 genome mark with a big-data 'cannonball'
Fierce Biotech IT |  15 January 2014
Illumina Introduces the HiSeq X Ten Sequencing System
Illumina (press release) |  14 January 2014
Illumina’s DNA Supercomputer Ushers in the $1,000 Human Genome
Bloomberg Businessweek |  14 January 2014
Is the $1,000 genome for real?
Nature |  15 January 2014
Science enters $1,000 genome era
BBC News |  15 January 2014
The $1,000 genome arrives - for real, this time
Forbes |  14 January 2014
23 January 2017 - by Kulraj Singh Bhangra 
Scientists have created a smartphone microscope attachment that can image and analyse DNA sequences...
29 February 2016 - by Ryan Ross 
The California-based genome-sequencing company Illumina has accused UK rival Oxford Nanopore Technologies of violating its intellectual property rights...
20 October 2014 - by Sean Byrne 
Illumina has announced the first three companies in its Accelerator Programme, designed to help genomics start-ups as other sources of funding grow scarce...
24 March 2014 - by Chris Baldacci 
IBM and the New York Genome Centre have teamed up to announce the latest weapon in the fight against cancer - Watson the supercomputer....
28 October 2013 - by Dr Lucy Freem 
A three-year joint project to sequence the genomes of 10,000 rare disease patients has been announced by the University of Cambridge, Genomics England and Illumina...
16 January 2012 - by Dr Zara Mahmoud 
A US biotechnology firm has unveiled an automated desktop DNA sequencer that can decode the sequence of the human genome in one day for as little as $1,000 (£650). Given its first public viewing at a consumer electronics show in Las Vegas, Life Technologies Corporation's Ion Proton sequencer uses microchips similar to those found in digital cameras...
17 August 2009 - by Dr Will Fletcher 
Third-generation 'single-molecule' technology has been used for the first time to read a human genome sequence. Professor Stephen Quake, from Stanford University, California, US, is only the eighth person whose genome has been published since the first breakthroughs were made in 2000. When this latest generation of technology is perfected the hope is that it will bring us one step closer to ‘the $1,000 genome' that will open the door to personalised medical treatme...
9 October 2006 - by Antony Starza-Allen 
The X Prize Foundation is offering $10m to the first private team that is able to sequence 100 human genomes in just ten days. It would currently take months, at the cost of millions of dollars, to sequence an individual human genome. Francis Collins, director of the...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.